Italian Azimut signs distribution agreement with insurer Amissima Vita

Eugenia Jiménez
clock
Italian Azimut signs distribution agreement with insurer Amissima Vita

Italy's Azimut has signed an agreement with the insurer Amissima Vita for the distribution of Vita's products to be placed through two investment solutions of Azimut.

Azimut's investment solutions Azimut protection and Azimut Safe Objective will be managed separately.

The deal represents a move forward in Azimut's growth plans in the retail and private banking networks.

Amissima Vita will make available to Azimut its financial expertise and that of its shareholder Apollo Global Management, in the management of traditional asset classes and those linked to the alternative credit segment.

Alessandro Santoliquido, managing director of Amissima Vita, said: "Thanks to the strength of Azimut's network of over 1,700 financial advisers and its innovative spirit, the firm has gained a leading position national and globally. Amissima Vita will support Azimut's development, offering products and services able to meet the needs of protection, safety and performance. Furthermore, the common focus on alternative investments will be a distinctive element of the partnership."

Paolo Martini, CEO of Azimut Capital Management, added:"The partnership with Amissima allows us to expand and strengthen the range of services offered within our open platform as well as to continue meeting our customers' needs.

Through it, we can also offer highly innovative management solutions like alternative credit ones thanks to the support of an international partner of great value."

More on Alternative

iM Global Partner rebrands Luxembourg-based Oyster fund range

iM Global Partner rebrands Luxembourg-based Oyster fund range

clock 10 January 2022 • 1 min read
Impax AUM exceeds £40bn at end of 2021

Impax AUM exceeds £40bn at end of 2021

Up 11.1% during ‘strong’ quarter

clock 10 January 2022 • 1 min read
Invesco looks to merge two Causer and Read income funds

Invesco looks to merge two Causer and Read income funds

Subject to shareholder approval

clock 07 January 2022 • 1 min read